Adipose-derived stem cell (ADSC) therapy offers a promising approach for individuals with chronic lung conditions, aiming to reduce inflammation, support lung tissue health, and promote overall pulmonary function.

By potentially aiding tissue health and supporting airway function, ADSC therapy may help manage symptoms and support the management of respiratory diseases, with the goal of enhancing quality of life for those with chronic lung conditions.

This non-invasive therapy provides a hopeful option for managing conditions such as asthma, COPD, and pulmonary fibrosis by targeting underlying tissue health and supporting long-term respiratory function.